A0A2I3GY64 (A0A2I3GY64_NOMLE) Nomascus leucogenys (Northern white-cheeked gibbon) (Hylobates leucogenys)

non-specific serine/threonine protein kinase UniProtKBInterProSTRINGInteractive Modelling

443 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: Q9Y6E0

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of MST3-MO25 complex with WIF motif Heteromer
Q9Y376; Q9Y6E0;
30-340
99.64ADP;MN;
Human MST3 (STK24) in complex with MO25beta Heteromer
Q9H9S4; Q9Y6E0;
32-301
100.0SO4;
Human MST3 (STK24) kinase in complex with inhibitor MR24homo-2-mer26-301
100.0VYN;EDO;
Human MST3 kinasemonomer18-310
66.67
MST3 in complex with CP-673451monomer18-310
66.6734U;EDO;PEG;
Human MST3 kinase in complex with ATPmonomer18-310
66.67ATP;
MST3 IN COMPLEX WITH CDK1/2 INHIBITOR III, 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUO…monomer18-310
66.67EDO;DKI;
Human MST3 kinasemonomer18-310
66.67
MST3 IN COMPLEX WITH AT-9283, 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZ…monomer18-309
66.6735R;ACT;EDO;CL;
MST3 IN COMPLEX WITH Imidazolo-oxindole PKR inhibitor C16monomer18-309
66.67EDO;34L;PG4;DMS;CL;
MST3 IN COMPLEX WITH PF-03814735, N-{2-[(1S,4R)-6-{[4-(CYCLOBUTYLAMINO)-5-(TRIFLUOROMETHYL)PYRIMIDI…monomer19-310
10034W;EDO;
MST3 IN COMPLEX WITH STAUROSPORINEmonomer20-310
100STU;CL;EDO;
Structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06645342)monomer24-311
99.313JB;
MST3 in complex with SARACATINIBmonomer24-311
99.31H8H;
Human MST3 kinase in complex with adeninemonomer25-311
99.3ADE;
Human MST3 kinase in complex with MnADPmonomer25-311
99.3ADP;MN;
MST3 IN COMPLEX WITH JNJ-7706621, 4-({5-AMINO-1-[(2,6-DIFLUOROPHENYL)CARBONYL]-1H-1,2,4-TRIAZOL-3-Y…monomer24-310
99.3SKE;MG;DMS;
MST3 IN COMPLEX WITH PP-121, 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRI…monomer24-310
99.3KS1;EDO;ACT;
Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06447475)monomer24-310
99.3MN;3FE;
Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06454589).monomer24-310
99.33JA;
MST3 IN COMPLEX WITH SUNITINIBmonomer25-311
99.3B49;CL;
MST3 in complex with HESPERADINmonomer27-311
100H1N;EDO;
MST3 IN COMPLEX WITH 2-(4,6-Diamino-1,3,5-triazin-2-yl)phenolmonomer27-311
100X11;
MST3 in complex with DASATINIBmonomer27-310
1001N1;EDO;CL;
MST3 in complex with BOSUTINIBmonomer27-310
100DB8;
MST3 in complex with AMP-PNPmonomer30-310
100EDO;MG;ANP;
MST3 IN COMPLEX WITH Danusertibmonomer30-310
100PGE;EDO;CL;627;
Crystal structure of sterile 20-like kinase 3 (MST3, STK24)monomer32-310
100.0HG;
Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporinemonomer32-310
100.0STU;
Human MST3 (STK24) kinase in complex with inhibitor MR30monomer25-301
100.0VZ2;EDO;
Human MST3 (STK24) kinase in complex with inhibitor MR26monomer26-301
100.0VYH; 11×EDO;
Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310monomer26-301
100.0VY0;EDO;
Human MST3 (STK24) kinase in complex with inhibitor MR39monomer26-301
100.0SJL;EDO;
MST3 in complex with MRIA7monomer26-301
100.0SQQ;
MST3 in complex with compound MRIA9monomer26-301
100.0SQ8;
MST3 in complex with MRIA11monomer26-301
100.0EDO;SQE;
MST3 in complex with compound MRIA12monomer26-301
100.0EDO;SQK;
MST3 in complex with compound G-5555monomer26-301
100.059T;
MST3 in complex with compound MRIA13monomer26-301
100.0SQB;
Human MST3 (STK24) kinase in complex with inhibitor MRLW5monomer26-301
100.0SJX;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4qmw.1.Amonomer0.8626-310
KS1;99.65